BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape is a research paper published in npj Precision Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R00CA246084-05
Elucidating the role of support signaling in promoting minimal residual disease in mouse models of oncogene-driven lung cancer
NCI NIH HHS
Grant: R00 CA246084
FWCI
6.19
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals